ETFs by Holding
ETFs That Hold Vertex Pharmaceuticals (VRTX)
Every fund in our data that holds VRTX as a top-10 position, with each fund's yield, fees and assets.
Holdings as of Oct 16, 2026 · 17 funds
Our holdings data as of Oct 16, 2026 lists 17 funds that hold VRTX as a top-10 position. BBH (VanEck Biotech ETF) has the largest weighting at 8.1%.
By dollars invested, IBB holds the most VRTX: about $814M, 7.5% of its $10.8B in assets.
14 of the 17 funds pay a distribution; the highest current rate is BIS at 4.60%. VRTX itself does not currently pay a dividend.
Largest VRTX holders by dollars invested
Diversified funds ranked by how much VRTX they own: assets under management times the VRTX weighting. A broad index fund with a modest weighting often owns more VRTX than every concentrated fund combined, so this order differs from the weighting table below. Leveraged and single-stock funds are left out because their reported weight is swap notional or a cash sleeve, not dollars of VRTX.
| Fund | Name | VRTX held | VRTX weight | AUM |
|---|---|---|---|---|
| IBB | iShares Biotechnology ETF | $814M | 7.52% | $10.8B |
| FTCS | First Trust Capital Strength ETF | $159M | 2.12% | $7.5B |
| LSGR | Natixis Loomis Sayles Focused Growth ETF | $39M | 4.26% | $920M |
| BBH | VanEck Biotech ETF | $39M | 8.05% | $482M |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | $20M | 4.75% | $412M |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $8M | 7.50% | $113M |
| GNOM | Global X Genomics & Biotechnology ETF | $3M | 3.18% | $107M |
| FFND | The Future Fund Active ETF | $2M | 1.64% | $96M |
| HELX | Franklin Genomic Advancements ETF | $780,139 | 2.61% | $30M |
| GDOC | Goldman Sachs Future Health Care Equity ETF | $763,592 | 3.98% | $19M |
Funds with the most VRTX by weighting
Every fund in the data, sorted by VRTX weight. Click any header to re-sort, or open a fund for its full analysis.
| Fund | Name | VRTX weight | Strategy | Distribution rate | Expense ratio | AUM | Distribution Safety Score™ |
|---|---|---|---|---|---|---|---|
| BBH | VanEck Biotech ETF | 8.05% | — | 0.40% | 0.35% | $482M | 94 |
| IBB | iShares Biotechnology ETF | 7.52% | — | 0.02% | 0.44% | $10.8B | 84 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 7.50% | — | 0.40% | 0.19% | $113M | 94 |
| BIS | ProShares UltraShort Nasdaq Biotechnology | 7.30% | Inverse / leveraged | 4.60% | 0.95% | $2M | — |
| GNMX | Corgi Genomics & Precision Medicine ETF | 5.59% | — | — | 0.35% | $3M | — |
| TBXU | Direxion Daily Biotech Top 5 Bull 2X ETF | 4.90% | Leveraged | 1.47% | 0.98% | $3M | 50 |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | 4.75% | — | 0.08% | 0.59% | $412M | 97 |
| BIB | ProShares Ultra Nasdaq Biotechnology | 4.48% | Leveraged | 0.32% | 0.95% | $88M | 52 |
| LSGR | Natixis Loomis Sayles Focused Growth ETF | 4.26% | — | — | 0.59% | $920M | — |
| HLTH | Tema Healthcare AI ETF | 4.00% | — | — | 0.75% | $11M | — |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 3.98% | — | 0.31% | 0.75% | $19M | 50 |
| GNOM | Global X Genomics & Biotechnology ETF | 3.18% | — | 0.18% | 0.50% | $107M | 50 |
| QFRD | Pacer S&P 500 Quality FCF R&D Leaders ETF | 3.00% | — | 0.08% | 0.49% | $2M | 50 |
| HELX | Franklin Genomic Advancements ETF | 2.61% | — | 0.28% | 0.50% | $30M | 50 |
| QNXT | iShares Nasdaq-100 ex Top 30 ETF | 2.50% | — | 0.65% | 0.20% | $28M | 94 |
| FTCS | First Trust Capital Strength ETF | 2.12% | — | 1.34% | 0.53% | $7.5B | 90 |
| FFND | The Future Fund Active ETF | 1.64% | — | 0.61% | 0.98% | $96M | 50 |
How to read this list
- Holdings come from each fund's ten largest positions. A fund that holds VRTX at a smaller weight is not listed.
- Weights are as reported by each fund on or before Oct 16, 2026 and move with prices between reports. Distribution rates are annualized from each fund's latest payment.
- This is a list of exposure, not a recommendation. Open any fund for its full record.
Frequently asked questions
Which ETF has the most VRTX?
BBH has the largest VRTX weighting in our data as of Oct 16, 2026, at 8.1%.
Which ETF holds the most VRTX in dollars?
IBB holds about $814M of VRTX: 7.5% of $10.8B in assets. A fund's weighting says how much of that fund is VRTX; the dollar figure says how much VRTX the fund owns, which is why a large index fund with a modest weighting can own more than every concentrated fund on the list.
How many ETFs hold VRTX?
17 funds hold VRTX as one of their ten largest positions in our data. Many more broad index funds hold it at smaller weights, which our top-10 holdings data does not cover.
Which ETFs that hold VRTX pay a dividend?
14 of the funds on this list pay a distribution. The highest current rates are BIS (4.60%), TBXU (1.47%), FTCS (1.34%). Sort the table by distribution rate to see the rest.
Does VRTX pay a dividend?
No. Vertex Pharmaceuticals does not currently pay a dividend, so a fund holding it earns no income from that position.